9 Results for "

HAEGTFTSDVSSYLE

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "HAEGTFTSDVSSYLE" in MCE Product Catalog:

Cat. No.: HY-P1445
CAS No.: 926018-57-7
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

HAEGTFTSDVSSYLE is a polypeptide from patent CN 102920658 B. GLP-I analog contains the sequence.
loading...
    loading...
Cat. No.: HY-114118S3
Purity:  96.04%
Semaglutide- 13C6, 15N TFA is the 13C- and 15N-labeled Semaglutide TFA (HY-114118A). Semaglutide TFA is a long-acting, selective, competitive GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide TFA promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide TFA also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide TFA has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide TFA can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer .
loading...
    loading...
Cat. No.: HY-P0014S1
Research Areas:  

Others

Liraglutide- 13C6, 15 tetraTFA is the 13C and 15N labeled Liraglutide (HY-P0014) . Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the study of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-P1228
CAS No.: 926018-95-3
Target:  

GCGR

Research Areas:  

Metabolic Disease

HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.
loading...
    loading...
Cat. No.: HY-P0014AS
Research Areas:  

Metabolic Disease

Liraglutide-d8 tetraTFA is deuterium labeled Liraglutide (HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the study of type 2 diabetes mellitus .
loading...
    loading...
Cat. No.: HY-P1224
CAS No.: 864915-61-7
Target:  

GCGR

Research Areas:  

Metabolic Disease

HAEGTFTSDVS is the first N-terminal 1-11 residues of GLP-1 peptide.
loading...
    loading...
Cat. No.: HY-P1226
CAS No.: 926018-45-3
Target:  

GCGR

Research Areas:  

Metabolic Disease

HAEGTFTSD is a 9-residue peptide of human GLP-1 peptide or GLP-1(7-36), amide (HY-P0054A). GLP-1(7-36), amide is a physiological incretin hormone that stimulates insulin secretionin a glucose-dependant manner
loading...
    loading...
Cat. No.: HY-P1230
CAS No.: 852155-81-8
Research Areas:  

Metabolic Disease

HAEGT is the first N-terminal 1-5 residues of glucagon like peptide-1 (GLP-1) peptide, and the sequence is His-Ala-Glu-Gly-Thr. HAEGT acts as a competitive substrate for probing prime substrate binding sites of human dipeptidyl peptidase-IV (DPP-IV) 1, in which the N-terminal His-Ala is catalyzed cleavage by DPP-IV. HAEGT can be used in the research of diabetes, obesity .
loading...
    loading...
Cat. No.: HY-P10312
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

SPN009 (Sequence 3) is a GLP-1 Receptor agonist, with EC50 of 2.84 nM. SPN009 attenuates the type II diabetes in DB/DB mice models .
loading...
    loading...